Century Therapeutics Ownership | Who Owns Century Therapeutics?
Century Therapeutics Ownership Summary
Century Therapeutics is owned by 46.81% institutional investors, 28.36% insiders, and 24.84% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 8.68% of IPSC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.55% of its assets in Century Therapeutics shares.
IPSC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Century Therapeutics | 46.81% | 28.36% | 24.84% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Bain capital life sciences investors | 5.41M | 8.68% | $13.80M |
Vr adviser | 5.39M | 8.65% | $13.74M |
Casdin capital | 5.19M | 8.33% | $13.24M |
Boxer capital | 4.90M | 7.87% | $12.50M |
Fmr | 2.95M | 4.74% | $7.52M |
Blackrock | 2.90M | 4.65% | $7.38M |
Vanguard group | 1.73M | 2.78% | $4.42M |
Dafna capital management | 1.70M | 2.74% | $4.35M |
Octagon capital advisors lp | 1.33M | 2.14% | $3.40M |
Adage capital partners gp | 1.32M | 2.12% | $3.37M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Syncona portfolio | 1.00M | 2.97% | $2.55M |
Bain capital life sciences investors | 5.41M | 1.51% | $13.80M |
Dafna capital management | 1.70M | 1.04% | $4.35M |
Casdin capital | 5.19M | 1.01% | $13.24M |
Vr adviser | 5.39M | 0.88% | $13.74M |
Boxer capital | 4.90M | 0.66% | $12.50M |
Octagon capital advisors lp | 1.33M | 0.53% | $3.40M |
Tang capital management | 900.00K | 0.23% | $2.29M |
Parametrica management | 27.84K | 0.09% | $70.99K |
Harbourvest partners | 29.02K | 0.04% | $74.00K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bain capital life sciences investors | 5.41M | 1.51% | 5.41M |
Boxer capital | 4.90M | 0.66% | 3.15M |
Casdin capital | 5.19M | 1.01% | 1.98M |
Vr adviser | 5.39M | 0.88% | 1.98M |
Blackrock | 2.90M | 0.00% | 1.40M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Avidity partners management lp | - | - | -1.22M |
Fmr | 2.95M | 0.00% | -420.95K |
Jacobs levy equity management | 10.58K | 0.00% | -283.36K |
Federated hermes | - | - | -276.16K |
Schonfeld strategic advisors | - | - | -93.08K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Bain capital life sciences investors | 5.41M | 1.51% | 5.41M | $13.80M |
Adage capital partners gp | 1.32M | 0.01% | 1.32M | $3.37M |
Syncona portfolio | 1.00M | 2.97% | 1.00M | $2.55M |
Corebridge financial | 24.68K | 0.00% | 24.68K | $62.94K |
Voya investment management | 17.44K | 0.00% | 17.44K | $44.46K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -6.00 |
Qube research | -334.00 |
Simplex trading | -2.42K |
Comerica bank | -2.95K |
Point72 (difc) | -6.43K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 68 | 11.48% | 39,649,236 | -1.17% | 46 | 1.96% | 31 | -20.51% | 16 | 33.33% |
Jun 30, 2024 | 60 | -10.45% | 40,117,758 | 73.62% | 64 | 4.24% | 39 | 39.29% | 11 | -50.00% |
Mar 31, 2024 | 67 | 6.35% | 23,106,280 | 30.72% | 38 | 4.41% | 28 | -17.65% | 22 | 10.00% |
Dec 31, 2023 | 63 | 14.55% | 17,675,612 | -2.13% | 29 | 3.20% | 34 | 70.00% | 20 | - |
Sep 30, 2023 | 55 | -15.38% | 18,061,121 | -6.38% | 30 | 2.81% | 20 | -16.67% | 20 | -16.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.31M | 1.55% | - |
Fidelity Growth Compy Commingled Pl S | 1.23M | 1.46% | 9.52K |
Fidelity Growth Compy Commingled Pl O | 1.22M | 1.45% | -96.60K |
iShares Russell 2000 ETF | 1.03M | 1.21% | -2.31K |
Syncona Ord | 1.00M | 1.18% | 1.00M |
Vanguard Institutional Extnd Mkt Idx Tr | 785.57K | 0.93% | - |
Fidelity Growth Company Fund | 746.17K | 0.88% | -1.58K |
Fidelity Small Cap Index | 477.39K | 0.56% | -841.00 |
Fidelity Growth Company K6 | 459.69K | 0.54% | -7.93K |
iShares Russell 2000 Value ETF | 418.22K | 0.49% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 04, 2024 | Farid Adrienne | Chief Operations Officer | Sell | $1.27K |
Nov 04, 2024 | Carr Douglas | SVP Finance & Operations | Sell | $347.24 |
Sep 12, 2024 | Quimi Daphne | - | Buy | $7.66K |
Aug 05, 2024 | Farid Adrienne | Chief Operations Officer | Sell | $1.96K |
Aug 05, 2024 | Carr Douglas | SVP Finance & Operations | Sell | $528.00 |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 2 |
2024 Q3 | 1 | 5 |
2024 Q2 | - | 7 |
2024 Q1 | - | 7 |
2023 Q4 | - | - |
IPSC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools